Born in Tanta, Egypt to Mohamed Mohamed and Zeinab Hussein Amer.
Immigrates to the United States.
Receives a Master of Science in pharmacology from the University of Illinois at Chicago.
Receives a Doctor of Philosophy in pharmacology from the University of Illinois at Chicago.
Becomes a senior research pharmacologist and project coordinator at Wilson Laboratories, Inc.
Becomes director of Cardiovascular Pharmacology at Mead Johnson & Co.
Is an invited speaker at the International Conference on the Physiology and Pharmacology of Cyclic AMP in Milan, Italy, and at Prostaglandins in Cell Biology in Carmel, Virginia.
Is an invited speaker at the Third American Peptide Symposium in Boston, Massachusetts.
Is an invited speaker at “The Possible Role of Cyclic Nucleotides in the Control of Gastrointestinal Function” in Princeton, New Jersey, and at AMP Changes in Disease in New York, New York.
Is an invited speaker at Cyclic Nucleotides in Disease in Philadelphia, Pennsylvania.
Is an invited speaker at Cyclic Nucleotides Systems, “A Target for Drug Design” in London, England.
Becomes director of Biological Research Responsible for all Pre-Clinical Work for Bristol-Myers International Division.
Is an invited speaker at the Gastrointestinal Pharmacology Group Conference in Princeton, New Jersey.
Is an invited speaker at Synthetic Cyclic Nucleotides and Therapeutics Perspectives in Paris, France.
Receives a Master of Business Administration in business from Columbia University.
Serves as president of Sam Amer & Co., Inc. in Santa Barbara, California.
Co-founds Amstell, Inc., where he serves as president.
Co-founds Top Laboratories, Inc., where he serves as president.
Co-founds Amer Particle Technology, Inc., where he serves as president.